Boobalan received his Master’s Degree in Chemistry from Virginia Tech, and his Ph.D. in Medicinal Chemistry from the University of Illinois at Chicago. He is a trained medicinal chemist whose research interests lie on the interface of computer-assisted drug design methods and organic synthesis. During his research years, he worked in several therapeutic areas, including Alzheimer's, oncology, infection (antibacterial and antimalarial) and epilepsy. Boobalan published his findings in 13 peer-reviewed journals. Owing to his contributions to the field of medicinal chemistry, the American Chemical Society bestowed upon him the highly prestigious Robert M. Scarborough Post-Graduate Excellence award in Medicinal Chemistry.
In the Hsu lab, Boobalan will be engaged in activities involving synthesis of all activity-based probes and small molecular inhibitors.